These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27620886)

  • 1. Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Otsuka T; Tomita H; Origasa H;
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27620886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Blood Pressure Visit-to-Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
    Kodani E; Inoue H; Atarashi H; Okumura K; Yamashita T; Otsuka T; Origasa H;
    J Am Heart Assoc; 2021 Jan; 10(1):e018585. PubMed ID: 33372541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):59-68. PubMed ID: 28950373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: A subanalysis of the J-RHYTHM Registry.
    Kodani E; Inoue H; Atarashi H; Okumura K; Yamashita T; Origasa H;
    Int J Cardiol; 2020 Mar; 302():81-87. PubMed ID: 31785960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry.
    Ishii M; Ogawa H; Unoki T; An Y; Iguchi M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
    Am J Hypertens; 2017 Nov; 30(11):1073-1082. PubMed ID: 28575205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Systolic Blood Pressure Time in Target Range on Adverse Events in Patients With Nonvalvular Atrial Fibrillation (from the J-RHYTHM Registry).
    Kodani E; Inoue H; Atarashi H; Okumura K; Suzuki S; Yamashita T; Origasa H;
    Am J Cardiol; 2022 Oct; 180():52-58. PubMed ID: 35909018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.
    Kumagai N; Nusser JA; Inoue H; Okumura K; Yamashita T; Kubo T; Kitaoka H; Origasa H; Atarashi H;
    Am J Cardiol; 2017 Jul; 120(2):230-235. PubMed ID: 28532776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry.
    Kario K; Hasebe N; Okumura K; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    Hypertension; 2022 Dec; 79(12):2696-2705. PubMed ID: 36259381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
    Proietti M; Romiti GF; Olshansky B; Lip GYH
    Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation　- Results of the J-RHYTHM Registry 2.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    Circ J; 2016; 80(4):843-51. PubMed ID: 27001190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation.
    Tsuda T; Hayashi K; Fujino N; Konno T; Tada H; Nomura A; Tanaka Y; Sakata K; Furusho H; Takamura M; Kawashiri MA; Yamagishi M;
    Heart Rhythm; 2019 Jun; 16(6):829-837. PubMed ID: 30503962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry.
    Tomita H; Okumura K; Inoue H; Atarashi H; Yamashita T; Origasa H; Tsushima E;
    Circ J; 2015; 79(8):1719-26. PubMed ID: 25971525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of CHA₂DS₂-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry.
    Okumura K; Inoue H; Atarashi H; Yamashita T; Tomita H; Origasa H;
    Circ J; 2014; 78(7):1593-9. PubMed ID: 24759791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation.
    Aakre CA; McLeod CJ; Cha SS; Tsang TS; Lip GY; Gersh BJ
    Stroke; 2014 Feb; 45(2):426-31. PubMed ID: 24309585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.